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Background: Elimination of malaria can only be achieved through removal of all vectors or complete depletion of
the infectious reservoir in humans. Mechanistic models can be built to synthesize diverse observations from the
field collected under a variety of conditions and subsequently used to query the infectious reservoir in great detail.
Methods: The EMOD model of malaria transmission was calibrated to prevalence, incidence, asexual parasite density,
gametocyte density, infection duration, and infectiousness data from nine study sites. The infectious reservoir was
characterized by age and parasite detectability with diagnostics of varying sensitivity over a range of transmission
intensities with and without case management and vector control. Mass screen-and-treat drug campaigns were tested
for likelihood of achieving elimination.
Results: The composition of the infectious reservoir is similar over a range of transmission intensities, and higher
intensity settings are biased towards infections in children. Recent ramp-ups in case management and use of
insecticide-treated bed nets (ITNs) reduce the infectious reservoir and shift the composition towards sub-microscopic
infections. Mass campaigns with anti-malarial drugs are highly effective at interrupting transmission if deployed shortly
after ITN campaigns.
Conclusions: Low-density infections comprise a substantial portion of the infectious reservoir. Proper timing of vector
control, seasonal variation in transmission intensity and mass drug campaigns allows lingering population immunity to
help drive a region towards elimination.
Keywords: Mechanistic model, Infectious reservoir, Diagnostics, Infectivity, Drug campaignsBackground
Malaria is a global disease responsible for hundreds of
thousands of deaths each year [1]. In the last decade,
many regions have made considerable progress in malaria
control and are now working towards local elimination of
malaria [2, 3]. Technical strategies for elimination differ
from those for control, and it is critical to understand the
factors that lead to successful outcomes and make the best
use of available resources.* Correspondence: jgerardin@intven.com
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creativecommons.org/publicdomain/zero/1.0/Elimination of malaria requires interrupting transmis-
sion. Complete depletion of the infectious reservoir of
malaria parasites requires clearing all malaria infections
in both human and vector populations. In regions where
malaria is endemic, accumulated exposure to infection
leads individuals to develop immunity to clinical symp-
toms and partial immunity to parasites. Proper identi-
fication of parasite carriers is therefore confounded by
a population of asymptomatic people with low-density
infections.
Current rapid diagnostic tests (RDT) can quickly and
cheaply identify individuals with parasite densities above
50–200 parasites per μL [4]. However, in endemic areas, a
significant portion of the population harbours infectionsarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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copy or molecular methods, both limited to research
laboratories, are required to identify infected individ-
uals. Although capable of detecting infections as low
as 0.01-0.05 parasites per μL, even the most sensitive
molecular tests today cannot detect all infections [5].
Asexual parasite density, gametocyte density and human
infectiousness are known to be linked [6, 7]. Higher asex-
ual densities lead to higher gametocyte densities, which
increase the chance of infecting mosquitoes. However, the
relationship between gametocyte density and infectious-
ness to mosquitoes is complex, as individuals with high
gametocyte density may infect few or no mosquitoes in
studies where captured mosquitoes are fed on human
blood, and individuals with no observable gametocytes
have been observed to be infectious [8, 9]. Human sexual-
stage and transmission-blocking immunity have been pro-
posed to play roles in moderating the relationship between
gametocyte density and infectiousness [10], but the mag-
nitude and duration of sexual stage immunity effects
remain unclear.
While most malaria infections in areas of even moder-
ate transmission are asymptomatic [11], the relative con-
tribution to the infectious reservoir of symptomatic and
asymptomatic, patent and sub-patent, and adult and child
populations remains an area of active investigation [12, 13].
Sub-patent individuals, even if they outnumber patent indi-
viduals, are less infectious to mosquitoes. In an elimination
setting, it is critical to understand how success may or
may not depend on appropriate targeting of sub-patent
infections, as sensitive diagnostics can be very resource-
intensive.
Mathematical modelling of malaria transmission and
immunity can begin to answer some of these questions
[12, 13]. A single mechanistic model can tie together
apparently contradictory field data that describe malaria
transmission in a variety of settings and demographic
groups. With a detailed model of within-host infection,
including parasite and gametocyte life cycles and dens-
ities as well as acquired immunity, the relative contribu-
tion to the infectious reservoir due to each sub-set of the
population can be compared and implications for control
and elimination can be quantitatively assessed.
A recent longitudinal study in a high-transmission area
of Burkina Faso used highly sensitive molecular detection
methods to quantify asexual and gametocyte densities,
providing invaluable data for model calibration [14] ethics
approval No. 2007-035/MS/MESSRS/CERS and 2014-0058/
MS/MERSI/CERS. This study also measured infectiousness
to mosquitoes with membrane feeding tests where 50 mos-
quitoes were fed on blood from each study participant and
subsequently dissected to determine oocyst counts. Using
this dataset and an agent-based stochastic model of malaria
transmission, adaptive immunity parameters were calibratedto best capture the age-dependent distribution of asexual
parasite and gametocyte densities. Next, oocyst positivity
from the membrane feeding data was used to calibrate
model parameters governing human infectiousness to mos-
quitoes. The calibrated model was then used to characterize
the composition of the infectious reservoir by detection
threshold and age group through seasonal variations and at
a range of transmission intensities. Changes in the infectious
reservoir after deployment of case management and vector
control are described. Finally, the implications for elimin-
ation campaigns are discussed by testing how mass drug
campaigns may successfully achieve elimination by targeting
all or only a portion of the infectious reservoir.
Methods
Malaria transmission model
All simulations were conducted with EMOD DTK v1.6,
an agent-based mechanistic model of malaria transmission
[15]. During the blood stage of malaria infection, asexual
parasite density triggers innate and adaptive immunity
within the host. Innate immunity stimulates cytokine pro-
duction, leading to fever in a density-dependent manner
and limiting the maximum parasite density. Adaptive
immunity is modelled using three types of antigens:
Plasmodium falciparum erythrocyte membrane protein
1 (PfEMP1) variants, merozoite surface proteins (MSP),
and minor epitope variants. Fuller discussion of immune
system modelling within the EMOD model is described in
[16–18]. Asexual parasite and gametocyte densities are
tracked within each host. Gametocytes differentiate from
infected red blood cells and mature in five stages over ten
days, and a fraction of gametocytes are lost at each stage
of maturation from implicit immune effects. Mature stage
gametocytes are taken up in a mosquito blood meal with
density-dependent probability, and human and mosquito
immune factors implicitly limit gametocyte survival within
the mosquito. Left untreated, all asexual and gametocyte
stage parasites will eventually be cleared by host immune
factors. Infectiousness of an individual human is calcu-
lated as a xenodiagnostic experiment measuring the frac-
tion of mosquitoes infected after feeding on the individual.
Calibration of asexual parasite and gametocyte densities
by age and season
Calibration of parasite densities built on previous work
in [19]. Data from nine study sites were used, including
four sites with age-stratified prevalence data: Namawala
in Tanzania and Matsari, Rafin Marke and Sugungum in
Nigeria, and two sites with age-stratified clinical incidence
data: Dielmo and Ndiop in Senegal, that span annual ento-
mological inoculation rates (EIRs) between 18 and over
300 and have been used in previous work [20–23]. Re-
cently available data from two sites, Dapelogo and Laye in
Burkina Faso, provided age- and season-stratified asexual
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lar methods [14]. Malariatherapy data on peak parasitaemia
and gametocytaemia as well as duration of parasitaemia
and gametocytaemia for single infections in naïve adults
were also included in the calibration [24].
Parameters under calibration included the maximum
number of simultaneous infections, number of PfEMP1
variants available to the parasite population, switching
rate between PfEMP1 variants, number of MSP variants,
number of minor epitope variants, killing strengths of
anti-MSP and anti-minor epitope immune responses, pro-
duction rate of gametocytes, and survival rate of gameto-
cytes as they progress through stages of maturation.
Prevalence and incidence sites were simulated and likeli-
hoods of calibration parameters were calculated as described
in [19]. Simulated individuals in endemic study sites
were subjected to an age- and month-dependent force ofFig. 1 Calibration of asexual parasite and gametocyte densities. a The distribu
group in reference data (open circles) and post-calibration simulation (filled c
of individuals and normalized for each season of each age group. b Example
after calibration for an age-6 child (solid lines) and age-28 adult (dotted lines)
low-transmission (bottom) settings. Each individual was challenged with a sin
administered and host immunity eventually cleared all parasitesinfection. Monthly EIR for Dapelogo and Laye followed
Burkina Faso seasonality and were based on available ento-
mological data, with an annual EIR of 300 for Dapelogo and
30 for Laye [25]. Malariatherapy simulations included a sin-
gle infectious bite on day 0 with no other infectious bites.
For malariatherapy simulations, asexual parasite and
gametocyte densities were measured daily in 1000 naïve
adults. For all other calibration study sites, a birth cohort
of 1000 children was followed for 100 years, and incidence
and prevalence measurements were gathered monthly and
annually to compare with field data.
In the likelihood function used to calibrate asexual para-
site and gametocyte densities, data from each age group
(under five, five to 15, over 15), season (start of wet season,
peak of wet season, dry season), study site (Dapelogo, Laye),
and parasite stage (asexual, gametocyte) were considered
separately (Fig. 1). Asexual parasite and gametocytetion of asexual parasite and gametocyte densities by season and age
ircles) is shown for two study sites. Circle area is proportional to number
infection trajectories of asexual parasites (blue) and gametocytes (green)
with immune histories corresponding to high-transmission (top) and
gle infectious bite on day 0, with no subsequent biting. No drugs were
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wet season), 1 September (peak of wet season), and 1
March (dry season), binned for each age group, and com-
pared with field data with a Dirichlet-multinomial
distribution.
For each parameter set θ
→
, the parasite/gametocyte
density distributions in each age group, site, and season
are binned into six density bins. The likelihood of par-
ameter set θ
→
given the data d (consisting of nd total
measurements, kd
→
counts in each bin,
X6
i¼1
kd; i ¼ nd ) is
approximated as follows. The prior distribution for the
multinomial probability vector p
→
associated with the six
bins is initially assumed to be a symmetric Dirichlet dis-
tribution with concentration parameter 1. The simulated
distribution of counts ks
→
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The joint likelihood is the product of likelihoods for
each age group, season, study site, and parasite stage,
which is also multiplied with the likelihoods from preva-
lence, incidence and malariatherapy comparisons to de-
termine the overall likelihood of each parameter set.
Likelihoods for prevalence and incidence are approximated
using a methodology similar to that described above
(detailed in [19]), using beta-binomial and gamma-Poisson
distributions, respectively.
For calibration to malariatherapy data, patients who
received anti-malarial treatment were removed from the
comparison data. All patients were assumed to have only
a single infection. Distributions of peak parasitaemia, peak
gametocytaemia, parasitaemia duration, and gametocy-
taemia durations were compared to simulation using a
Dirichlet-multinomial likelihood as described above.
Parameter sampling was done by incremental mixture
importance sampling (IMIS), as described in [26]. Finalbest-fit parameter values are shown in Additional files 1
and 2 and comparison with study site data shown in
Additional file 3. Malariatherapy data were weighted at
10 % relative to data from endemic areas in the likeli-
hood function, as full weighting of malariatherapy data
resulted in poorer fitting to prevalence data, particu-
larly at the Rafin Marke study site (in Additional file 4).
Infections from malariatherapy studies appear to have
relatively short durations compared to what would be
expected based on data collected from endemic sites. The
malariatherapy dataset used in calibration, which did not
include any patients who received curative treatment with
drugs, may be biased towards milder infections. Strain dif-
ferences between parasites used for malariatherapy and
parasites in endemic regions may also account for the dis-
crepancies. Differences in infection duration between
strains have been noted previously, with El Limon showing
long infections, McLendon showing short infections, and
Santee Cooper showing both long and short infections [18].
Calibration of infectiousness by age and season
Human infectiousness to mosquitoes was calibrated to
membrane feeding data stratified by age, season and study
site [14]. Simulations used the immunity, infection and
gametocyte development parameters in Additional file 1.
A population of 1000 individuals of all ages was subjected
to 50 years of forced EIR to initialize age-appropriate im-
munity, with EIR values as described above for the Dape-
logo and Laye sites. Calibration also used forced EIR and
no vectors.
Two parameters, the survival rate of gametocytes in
the mosquito and the maximum probability a mos-
quito becomes infected, were calibrated using IMIS as
described above. For each sampled parameter set, the
distribution of fraction mosquitoes infected was com-
pared to field data with a Dirichlet-multinomial as
described above. Infectiousness by age group (under
five, five to 15, over 15) and season (start of wet season,
peak of wet season, dry season) were considered
separately, and likelihoods were multiplied. Calibrated
parameter values are shown in in Additional file 2 and
simulated infectiousness compared with field data in
Fig. 2.
Characterization of the infectious reservoir in full vector
transmission model
Simulations of the infectious reservoir were conducted
with a full vector transmission model in a Burkina Faso
climate with vector abundance calibrated to achieve an-
nual EIR between 200 and 300. Vector species included
Anopheles gambiae and a small amount of Anopheles
funestus, and larval habitats were modelled as in
[27] with enough constantly available habitat to ensure
vector survival through the dry season. Vector feeding
Fig. 2 Calibration of human infectiousness to mosquitoes. The relationship between gametocyte density and infectiousness by season and age
group in reference data (open circles) and post-calibration simulation (filled circles) is shown for two study sites. Circle area is proportional to
number of individuals and normalized for each season of each age group
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gic; other vector life cycle parameters were modelled
as in [27]. Population demographics followed the Burkina
Faso age structure [28], including birth and age-
dependent mortality. All simulations were performed
on a well-mixed population of 1000 individuals. Larval
habitat was scaled to simulate settings with lower trans-
mission intensity (Additional file 5). Simulation of each
transmission intensity was repeated for 1000 stochastic re-
alizations, and all figures show mean measurement values.
Populations were simulated for 50 years at each transmis-
sion intensity in the absence of interventions to initialize
age-appropriate immunity. Importation of cases occurred
at a rate of one per year. All simulations included one year
of equilibration prior to three years of measurement.Individuals were assigned to detection groups on each
day of the detection period. Each individual was tested
for asexual parasite positivity at three diagnostic sensitiv-
ity levels: 100, 10 and 0.05 asexual parasites per μL and
assigned to the least sensitive diagnostic to which they
tested positive. Individuals tested positive if a random
draw from a Poisson distribution centred at the true
number of asexual parasites in 1/(diagnostic sensitivity) μL
of blood was non-zero. Individuals testing negative by all
diagnostics, but nonetheless infected with asexual parasites,
were assigned to the undetectable group.
Host size is known to predict mosquito biting behav-
iour, and an age-dependent biting risk was included to
approximate surface area dependence [29–31]. Compos-
ition of the infectious reservoir is calculated by normalizing
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values and stochastic variations between simulation runs
does not qualitatively change the composition of the in-
fectious reservoir (Additional file 6).
Modelling case management and campaigns with
insecticide-treated bed nets (ITNs)
Several simulation scenarios are modelled: baseline ‘no inter-
vention’ scenarios with no case management or ITNs; case
management scenarios where symptomatic individuals could
access treatment with anti-malarial drugs, but no ITNs; ITN
campaign scenarios where ITNs were distributed to the
population in an age-dependent manner, but no case man-
agement was available; and, scenarios that included both
ITN distribution and case management.
Case management was available to simulated individuals
with clinical or severe malaria. A clinical case occurred when
an individual’s body temperature increased by at least 1.5 °C,
and severe cases occurred when fever, anaemia or parasite
density exceeded thresholds described in [19]. Ninety-five
per cent of the population had any access to case manage-
ment. Of the population with access to case management,
individuals with clinical malaria had 60 % probability of seek-
ing care for a given episode. Individuals with severe malaria
had 95 % probability of seeking care. All individuals
seeking care received treatment with artemether-
lumefantrine (AL) within three days for clinical cases or
two days for severe cases, and all treated individuals com-
pleted the full course of treatment with full adherence.
Age-dependent dosing, pharmacokinetics and pharmaco-
dynamics of AL were modelled as described in [32]. Simu-
lations with case management allowed case management
during both the equilibration and measurement periods.
ITNs were distributed at birth with 90 % coverage and
were also mass distributed on day 200 of the first meas-
urement year with 80 % coverage for children under ten
and 50 % for individuals over ten years of age. ITNs had
an initial blocking rate of 90 % and killing rate of 60 %,
with efficacy decaying exponentially with half-lives of two
years and four years, respectively. When ITNs were present,
the contribution of ITN-protected individuals to the infec-
tious reservoir was reduced by the ITN blocking rate after
scaling by surface area as discussed above.
Annual EIR was measured by summing the daily infec-
tious bites per person over the second measurement
year. For the same amount of larval habitat, case man-
agement and ITNs reduced the apparent EIR relative to
simulations without interventions. When case manage-
ment and/or ITNs were present, the plotted EIR is the
apparent EIR experienced by the simulated population.
Simulation of mass drug campaigns
Mass drug campaigns were conducted with dihydroartemi-
sinin-piperaquine (DP), with improved paediatric dosing asdescribed in [33] and pharmacokinetics and pharmaco-
dynamics as in [32]. All individuals receiving DP adhered
to the full treatment course. Mass campaigns were con-
ducted during the second and third measurement years in
three rounds per year separated by six weeks, with the first
round occurring on day 60 of the second measurement
year. All covered individuals received DP on the same day.
Coverage was independent between rounds. Importation
of cases occurred at a rate of one per year.
Mass campaigns were tested at apparent EIRs between
0.07 and 40 for settings with no other interventions and
settings with case management and ITN use as described
above. Drug campaign coverage was tested at 0, 20, 40, 60,
80, and 100 %. Interpolations were calculated with the
SciPy v0.14.1 interpolate function in Python 2.7. Mass
screen-and-treat (MSAT) campaigns used diagnostics with
sensitivity 100, 20 or 2 asexual parasites per μL. Simulation
of each EIR, coverage and MSAT diagnostic sensitivity was
repeated for 100 stochastic realizations.
Elimination was determined to be achieved if true asex-
ual parasite prevalence was 0 for the last 150 days of simu-
lation year 3. Probability of elimination was the fraction of
the 100 stochastic realizations resulting in elimination.
Results
Composition of the infectious reservoir in the absence of
interventions
Adaptive immunity and human infectiousness parameters
within an agent-based model were calibrated to age- and
season-stratified data from two high-transmission areas in
Burkina Faso (Figs. 1 and 2) (see Methods). Typical infec-
tion trajectories in the calibrated model show shorter
durations of infection and lower parasite densities in
adults, especially in high-transmission settings (Fig. 1b
and Additional file 7). Gametocyte clearance lagged be-
hind asexual parasite clearance, and all infections were
eventually cleared by host immunity.
Figure 3a shows the infectious reservoir over three years
in a moderate-transmission setting with annual EIR of 10
and the seasonality of Burkina Faso. Total asexual parasite
prevalence peaks towards the end of the rainy season and
is largely due to a large increase in higher-density infec-
tions. Prevalence of RDT-negative, microscopy-positive
infections as well as infections positive by PCR only and
undetectable infections remained relatively more constant
through the year, peaking towards the beginning of the
dry season as the RDT-positive infections began to clear.
For this work, the limit of detection for microscopy is
considered to be the gold-standard 10 parasites/μL achiev-
able in research facilities rather than the 100 parasites/μL
more common in the field.
Total infectiousness was quantified by measuring the
probability of each individual infecting a mosquito and
scaling by age to approximate the decreased biting risk
Fig. 3 Composition of the infectious reservoir in the absence of interventions.a The composition of the infectious reservoir by diagnostic detectability
and age in a setting with moderate transmission. A region of EIR = 10 was simulated over three years with seasonal rainfall and temperature based on
Burkina Faso climate. The entire population was tested for asexual parasite prevalence daily for three years with diagnostics at three levels of sensitivity:
100 parasites/μL (bottom 3 stripes, pink), 10 parasites/μL (3 stripes second from bottom, yellow), and 0.05 parasites/μL (3 stripes third from bottom, blue).
Infections undetectable at 0.05 parasites/μL are shown in grey (top 3 stripes). Infectiousness was calculated by simulating a membrane-feeding test and
subsequently scaling by age to approximate surface area effects. The fraction of the infectious reservoir is the normalization of total infectiousness. The
average of 100 stochastic realizations is shown. b Annual average composition of the infectious reservoir under a range of transmission intensities. All
measurements were averaged over the second year of simulation. 1000 stochastic realizations were averaged for each EIR level
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Total infectiousness exhibits more seasonal variation than
asexual parasite prevalence since transmission to mosqui-
toes is dominated by RDT-positive individuals, and higher
parasite density leads to greater infectiousness.
Under these conditions of moderate transmission and
high seasonality, the composition of the infectious reser-
voir shows considerable variation through the year. RDT-
positive individuals comprise over 60 % of the infectious
reservoir during the wet season but only 30 % during
the dry season. Sub-microscopic infections account for
20-40 % of the infectious reservoir at any time of year,
a substantial portion.
While children have higher parasite densities and are
highly infectious (Figs. 1 and 2), their smaller surface area
reduces their contribution to the total infectiousness of
the population. Children contribute the most to the infec-
tious reservoir at the beginning of the dry season when
adult immune systems have already reduced parasite load
in adults, leaving children to slowly clear their longer in-
fections and continue transmission (Fig. 1b).To compare the infectious reservoir across a range of
transmission intensities, the seasonal variation in asexual
parasite prevalence and total infectiousness were averaged
over a year of simulation (Fig. 3b). Total asexual parasite
prevalence increases steeply as EIR increases from <0.1 to
1 infectious bite per person per year. Above EIR = 1,
asexual parasite prevalence increases more gradually and
approaches 100 % for EIR >100. Total population infec-
tiousness also increases steeply as EIR increases towards 1
but is nearly constant for EIRs between 1 and 200, consist-
ent with observations in a study area where the proportion
of infected mosquitoes remained roughly constant while
slide prevalence in humans declined nearly four-fold [34].
RDT-detectable infections comprise 20-30 % of all in-
fections over the entire sampled range of transmission
intensities, with higher EIR settings showing relatively
more RDT-detectable infections (Additional file 8). These
observations are consistent with the proposed hypothesis
that individuals in high-transmission settings are constantly
subjected to bursts of high parasite density from new
infections, while individuals in low-transmission settings
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treated single infections are cleared by immune activity [12].
RDT-detectable infections represent a similar proportion
of the infectious reservoir regardless of transmission inten-
sity, as do microscopy-detectable and PCR-detectable in-
fections. Populations in regions with very low transmission
intensity (EIR <1) have slightly more of the infectious
reservoir contributed from RDT-positive individuals, while
RDT-negative individuals form an increasingly large
portion of the reservoir as EIR increases above 1.
Children contribute more to the infectious reservoir at
the highest transmission intensities (EIR >100). At high
transmission intensity, adult immunity retains memory
of a large repertoire of antigenic variants, and therefore
parasite density is unlikely to remain above the RDT de-
tection limit for long. In this situation, children comprise
a larger portion of the RDT-positive population. At low
transmission (EIR <1), children under five barely contrib-
ute to the infectious reservoir, and children between
five and 15 contribute only 20 %. Adults are the majorFig. 4 Composition of the infectious reservoir by diagnostic detectability a
nets (ITNs) under a range of transmission intensities. a The infectious reserv
is available. All treated individuals received a full course of artemether-lume
treatment availability and conditions for seeking care. b The infectious re
ITNs. See Methods for details of ITN distribution and effectiveness. Scaling
usage. c Comparison of the infectious reservoir at apparent EIR of 1 under codrivers of transmission in all but the highest transmis-
sion settings.Composition of the infectious reservoir after recent ramp-up
in case management and ITN use
Regions considering elimination are likely to have already
implemented vector control and strengthened their health
systems. Aggressive case management and campaigns
with ITNs on the infectious reservoir were modelled. Both
case management and ITN campaigns decreased the
observed EIR (Additional file 9).
Under case management with AL, where 95 % of the
population has access to care, 60 % of clinical cases seek
treatment and 95 % of severe cases seek treatment, the
total infectious reservoir is reduced (Fig. 4a) compared
to simulations without case management (Fig. 3b). At low
transmission (EIR <1), case management is particularly ef-
fective at depleting the infectious reservoir, as infections
are more likely to become clinical cases and treatment ofnd age with case management and deployment of insecticide-treated
oir under a range of transmission intensities when case management
fantrine (AL) with age-dependent dosing. See Methods for details of
servoir under a range of transmission intensities after deployment of
human infectiousness for age biting risk included effects of net
nditions of no intervention, case management with AL and ITN use
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reservoir.
An ITN campaign was simulated with ITN use skewed
towards children (see Methods), as has been recommended
for control situations [35]. Each individual’s infectiousness
was scaled by the ITN blocking rate if the individual re-
ceived an ITN in the simulation. Because ITNs interrupt
transmission by killing vectors and blocking feeds, deploy-
ment of ITNs substantially reduces the infectious reservoir
at all transmission levels (Fig. 4b). Children under five
comprise an even smaller portion of the infectious reser-
voir than the case with no ITNs, even at high transmission.
Relative to no interventions, high case management
and ITN usage decrease the overall infectiousness of
the population and bias the infectious reservoir towards
RDT-negative and sub-microscopic infections, especially
for low-transmission settings. Case management and ITN
use, which are biased towards children, further shift the
infectious reservoir towards adults. At the same observed
annual EIR of 1, settings where EIR has recently been re-
duced by case management or ITNs show a larger fraction
of the infectious reservoir stemming from sub-patent
infections relative to settings where EIR has historically
been at 1 (Fig. 4c). Settings where EIR has recently
been reduced to 1 have populations whose immune
systems are adapted to EIR >1, so quickly reducing EIR
leads to infections with lower parasite density. If the
reduced EIR is maintained for many years, population
immunity will rebound [36], and the composition of
the infectious reservoir will lean more towards RDT-
positive individuals.Depletion of the infectious reservoir after mass drug
campaigns
The probability of elimination following MSAT campaigns
with DP was tested at various levels of MSAT diagnostic
sensitivity, coverage and transmission intensity (Fig. 5a).
Three rounds of MSAT with independent coverage were
applied during the dry season for two years. An improved
paediatric formulation of DP was administered to avoid
under-dosing in young children [33, 37]. The MSAT cam-
paign outcomes were compared to mass drug administra-
tion (MDA), where all individuals are treated, as well as
MSAT campaigns where case management and ITNs have
recently reduced EIR.
High coverage, high MSAT diagnostic sensitivity and
low transmission all increase the likelihood of elimination
following an MSAT campaign. Higher coverage cannot
completely compensate for lower diagnostic sensitiv-
ity, and elimination is not possible for settings with
EIR >1 when an MSAT is conducted with current
RDTs, which have sensitivity around 100 parasites per
μL. A field trial of an MSAT campaign in a BurkinaFaso site with asexual parasite prevalence between 30
and 50 % showed little success with long-term preva-
lence reduction [38].
Case management and ITN use increase the likelihood
of elimination by MSAT. Under the same transmission
intensity, lingering population immunity helps push a re-
gion towards elimination after a drug campaign if EIR
has recently been reduced (Fig. 5b). The bonus from lin-
gering immunity increases with better coverage, underscor-
ing the critical importance of treating as many people as
possible in a drug campaign. Simulation results also sug-
gest that lingering immunity may be most beneficial for
elimination efforts at EIR between 1 and 10, where EIR is
low enough that elimination is possible but high enough
that adult immunity is strong.
Discussion
To interrupt the chain of malaria transmission, it is crit-
ical to identify who is transmitting. Here a mechanistic
model of within-host parasite and immune dynamics
was calibrated to field data on gametocyte densities and
transmission probabilities. The model was then used to
predict the infectious reservoir of malaria by age group
and parasite detectability over a wide range of transmis-
sion intensities.
While high-quality field data is essential for understand-
ing malaria transmission, models are also invaluable for
showing that data from diverse geographic, demographic
and intervention conditions can arise from the same
underlying mechanisms. In this work, malariatherapy
data on infection duration is incompatible with preva-
lence measurements from endemic areas in the EMOD
model framework, highlighting a likely area for model
improvement.
Because the EMOD model was calibrated to data
from endemic areas of moderate to high transmission,
extrapolations to low-transmission simulations are less
certain, especially in light of the calibrated parameteri-
zation’s differences from malariatherapy data. Measure-
ments of average annual parasite prevalence from endemic
areas predict infections to last longer than is observed in
malariatherapy patients. It is possible the model is operat-
ing in a sub-optimal regime of P. falciparum antigenic vari-
ants for reasonable predictions of the infectious reservoir
at EIR = 0.1, as strain diversity can be much lower in low-
transmission settings [39]. Long-term exposure to a few
strains could lead to populations with many low-density in-
fections and very few clinical cases, biasing the infectious
reservoir towards less detectable infections. New know-
ledge of parasite prevalence, densities and infectiousness in
low-transmission study sites will be incorporated into the
model as data becomes available.
While adaptive immunity towards asexual parasites is
fairly well understood, it remains unclear how sexual stage
Fig. 5 Depletion of the infectious reservoir after mass drug campaigns with dihydroartemisinin-piperaquine (DP). a Probability of elimination after
two consecutive years of mass drug campaigns at three rounds per year. See Methods for details of timing of campaign rounds. Case management
and ITNs were simulated as in Fig. 4. Probability of elimination was the fraction of 100 stochastic realizations resulting in complete elimination of all
parasites by the end of year 3. Coverage was independent for all rounds and all interventions. For simulations with case management and ITNs, EIR is
the EIR that would have been experienced during the second year of simulation had the drug campaigns not been administered. Crosses indicate the
EIR, coverage and MSAT diagnostic sensitivity simulated in panel B. b The infectious reservoir before, during and after MSAT campaigns in areas with
apparent EIR = 1, MSAT diagnostic sensitivity 20/μL, and 80 % coverage. Left: asexual parasite prevalence and human infectiousness in an endemic
region with EIR 1 and no interventions. Right: asexual parasite prevalence and human infectiousness in a region where case management and ITN
campaigns have reduced EIR to 1
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the host and ability to continue the parasite life cycle
within the vector [10, 25, 40–42]. The EMOD model of
host immunity did not include any immunity towards
gametocytes, and the trend of lower gametocyte density
with age is due entirely to lower asexual parasite densities.
Comparison of calibrated simulations of gametocyte dens-
ity to observed distributions of gametocyte densities does
not suggest that sexual stage immunity plays a strong role,
at least in the high-transmission settings where the data
were collected.
Transmission-blocking immunity, where individuals
with high gametocyte counts fail to infect a large portion
of feeding mosquitoes, has also been proposed. Calibration
of the EMOD model suggests that transmission-blockingimmunity may exist, as the model systematically failed to
replicate data where individuals with gametocyte dens-
ities >1000/μL were sometimes observed to infect <5 %
of mosquitoes. The model also does not account for cases
where individuals with very low or undetectable parasite
density have been observed to infect mosquitoes [43].
Thus the contribution to the infectious reservoir of people
with high-density infections may have been overestimated,
implying that RDT-negative infections are even more
critical to target than the analysis suggests. Measurement
uncertainty of molecular methods could also play a role
in overestimation of gametocyte densities [44]. In addition,
direct skin feeding is known to infect mosquitoes at a
higher rate than membrane feeds [45]. Future data
collection on transmission by direct skin feeding or
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invaluable for improving models of malaria transmission
and understanding the nature of the infectious reservoir.
Simulations show that children comprise a large portion
of the infectious reservoir only at very high transmission
intensity, and adults (aged over 15 years in the simulations)
are the main drivers of transmission in low to moderate
transmission settings. These results are for annual aver-
ages, but the infectious reservoir also varies seasonally, and
relative contribution from children increases at the end of
the wet season when adult infections have largely cleared.
The age structure of the infectious reservoir will also
change if mobile adults are re-importing infections from
another setting where transmission is less seasonal or if
one age group is spending more time outdoors in an area
where transmission by outdoor-biting vectors is signifi-
cant. Local patterns of behaviour and entomology can lead
to region-specific patterns of exposure and thus region-
specific infectious reservoirs.
Based on warnings that paediatric dosing of DP is in-
sufficient, dosage of DP in the simulations was increased
over current recommended levels. Drug campaign outcomes
improved compared to previous work, which followed
current guidelines for dosing, particularly in increasing
the probability of elimination at EIR >10 at moderately
high coverage levels [32]. While correct dosing is import-
ant for reducing the chance of recrudescence in individual
patients, under-dosing is particularly critical to avoid in an
elimination scenario, as interrupting transmission cannot
occur when a sub-group of the population can continue
to harbour and transmit infection or when a sub-group
does not receive the benefits of prophylaxis.
Compared to settings where no interventions have per-
turbed the EIR for a long period, settings where EIR has
recently been reduced show a shift in the infectious res-
ervoir towards younger individuals and towards lower
density infections. This may suggest that MSAT campaigns
should achieve lower success rates in settings with recently
reduced EIR because diagnostics will miss a greater frac-
tion of the infectious reservoir. However, simulations show
that MSAT campaigns are actually more successful in set-
tings with recently reduced EIR because strong population
immunity more than compensates for ongoing transmis-
sion from low-density infections.
Simulations of MSAT campaigns predict that proper
timing of drug campaigns relative to ITN deployment may
be critical to harness the power of lingering immunity in
order to drive the region towards elimination. However,
there is a lack of data to properly calibrate the rate of im-
munity decay, and predictions of likely elimination may
be optimistic. While gathering such data may prove ex-
tremely challenging, a thorough understanding of immun-
ity decay is critical for meaningful modelling of elimination
scenarios.Conclusions
Composition of the infectious reservoir varies seasonally,
with higher density infections forming a larger portion
during the high-transmission season. RDT-negative in-
fections make up a substantial portion of the infectious
reservoir over a wide range of transmission intensities. The
increased infectiousness of children due to higher gameto-
cyte densities is balanced by decreased propensity to be
bitten due to smaller surface area. Adults comprise the
largest fraction of the infectious reservoir at low to moder-
ate transmission intensities, while children form the lar-
gest portion only in very high transmission settings.
Interventions such as case management and ITN use
tilt the infectious reservoir towards sub-microscopic infec-
tions. Mass campaigns with anti-malarial drugs are more
successful when they reach a larger portion of the in-
fectious reservoir through more sensitive diagnostics or
higher coverage. Proper timing of drug campaigns with
seasonal variation in transmission intensity as well as
recent deployment of ITNs allows lingering population
immunity to help drive a region towards elimination.Additional files
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